ANEB Stock Earnings: Anebulo Pharmaceuticals Beats EPS for Q3 2024

Date:

May 16, 2024

Anebulo Pharmaceuticals (NASDAQ:ANEB) just reported results for the third quarter of 2024.

Anebulo Pharmaceuticals reported earnings per share of -6 cents. This was above the analyst estimate for EPS of -12 cents.
The company did not report any revenue for the quarter.

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Go Source

SXTP Stock Earnings: 60 Degrees Reported Results for Q1 2024

DPSI Stock Earnings: DecisionPoint Sys Misses EPS, Misses Revenue for Q1 2024